Three Bays Capital’s Allergan plc AGN Stock Holding History

Three Bays Capital’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-150,000	Closed	-$46.9M	–	24
2015 Q4	$46.9M	Hold	150,000	–	–	2.11%	14
2015 Q3	$40.8M	Buy	+150,000	New	+$46.1M	2.04%	12

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Three Bays Capital's AGN Position: Q1 2017 in Review

Three Bays Capital sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 212,297 shares — an estimated $44.6M sold.

Three Bays Capital first reported a position in AGN in Q4 2014 and held it in 9 quarters. The position peaked at $152M in Q4 2015. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

Three Bays Capital reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
Three Bays Capital sold 212,297 Allergan plc shares in Q1 2017, an estimated $44.6M.
Three Bays Capital first reported a position in Allergan plc in Q4 2014 and held it in 9 quarters.
Three Bays Capital's Allergan plc position peaked at $152M in Q4 2015.
1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Three Bays Capital's 13F filing for Q1 2017, filed 15 May 2017.